Tag: schizophrenia
There is a new drug that promises to have fewer side effects
Bristol-Myers Squibb has approved its drug Cobenfy for the treatment of schizophrenia. It aims to reduce the negative symptoms like apathy and lack of motivation. It will be available from October at $1,850 a month, according to the company. Cobenfy is a monoclonal antibody that binds to muscarinic receptors, a group of receptors found in the gut and the brain.
Read More
A student explores mental health issues
Speaking about schizophrenia, a chronic mental health condition where a person experiences symptoms of schizophrenia like delusions and depression, ‘The Monsters we create’ host Sammy Davis said, “Three in 1,000 people experience it and that’s why it’s rare.” “I’m not delusional…I’m just one more guy, with a mental health condition, living with it,” he added.
Read More